Andreas Halvorsen's EW Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 3.07 M shares of Edwards Lifesciences Corporation (EW) worth $238.69 M, representing 0.62% of the portfolio. First purchased in 2019-Q3, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 2.59 M shares. Largest reduction occurred in Q4 2019, reducing 136,725 shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Andreas Halvorsen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2019 | +612,444 | New Buy | 612,444 | $73.30 |
| Q4 2019 | -136,725 | Reduce 22.32% | 475,719 | $77.76 |
| Q1 2020 | -475,719 | Sold Out | 475,719 | $0.00 |
| Q3 2025 | +3.07 M | New Buy | 3.07 M | $77.77 |
Andreas Halvorsen's Edwards Lifesciences Corporation Investment FAQs
Andreas Halvorsen first purchased Edwards Lifesciences Corporation (EW) in Q3 2019, acquiring 612,444 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Edwards Lifesciences Corporation (EW) for 25 quarters since Q3 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen's largest addition to Edwards Lifesciences Corporation (EW) was in Q3 2025, adding 3,069,151 shares worth $238.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 3,069,151 shares of Edwards Lifesciences Corporation (EW), valued at approximately $238.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.62% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen's peak holding in Edwards Lifesciences Corporation (EW) was 3,069,151 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.